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Brooke-Spiegler syndrome (BSS) includes the combination of spiradenomas, 
cylindromas, and trichoepitheliomas. It has been postulated that BSS results from 
defects in the regulation of putative stem cells of the folliculosebaceous-apocrine unit.1 
This follicular dysregulation may give rise to 3 different genodermatoses: familial 
cylindromatosis (FC), multiple familial trichoepithelioma (MFT), or the classic triad of 
BSS. 
The gene for FC was mapped to chromosome 16q12-q13.2 At present, 32 different 
germline mutations in the CYLD gene have been described,3 20 in families with FC, 8 
in families with MFT, and 4 in families with BSS. Taken together, these observations 
suggest that these inherited syndromes associated with skin appendage tumors not only 
share a common genetic basis but also may represent phenotypic variation of the same 
disease.4 
REPORT OF A CASE 
An 8-year-old girl came to our department with her parents. Her mother, grandmother, 
and 2 aunts were diagnosed as having trichoepithelioma since childhood (Figure 1). The 
parents of our patient wanted to know if their daughter might harbor any genetic 
susceptibility for these cutaneous lesions. 
Blood samples were obtained from available family members and 110 unrelated 
controls. Genomic DNA was extracted; all coding exons were amplified by polymerase 
chain reaction; and further sequencing analysis was performed. We identified 1 
mutation not previously reported. The mutation was found in all patients but not in the 
healthy members of this family. The change was a point mutation in exon 20 (G2687C) 
that resulted in substitution of glycine at 896 by alanine (Figure 2). The mutation was 
not detected in 110 unrelated controls. 
 
COMMENT 
Herein, we report a novel CYLD gene mutation at nucleotide 2687 that carries out 1 
amino acid change at glycine 896 in the 4 affected members of this family but not in the 
proband. The fact that we have not detected this change in 110 unaffected controls 
makes a contribution to the genotype-phenotype correlation in MFT. 
The CYLD gene is considered a negative regulator of nuclear factor kappa B(NF-κB).5 
Thereby, inhibition or inactivation of CYLD enhances the action of NF-κb and leads to 
increased resistance to apoptosis and carcinogenesis.6
To our knowledge, this mutation has not been previously described. The known 
mutations of the CYLD gene are mostly located in the C-terminal portion. 
Germline mutations display tissue-specific function loss. Another possibility would be 
that the germline mutation determines the tissues where the preferred second hit occurs. 
When the second hit occurs in eccrineapocrine cells, the patients become susceptible to 
multiple cylindromas; in hair follicle cells, the patients exhibit susceptibility to multiple 
cylindromas or MFT.6
Our study shows the importance of mutation screening of the CYLD gene in patients 
affected with FC and MFT as well as their relatives to identify early clinical 
manifestations. Analysis of control volunteers in this report confirms the role of this 
missense mutation as the cause of this syndrome. Further studies evaluating the effect of 
this mutation in animal models must be considered. 
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Figure 1. Clinical picture (A) and family pedigree (B) for the present case. A, Multiple 
trichoepitheliomas are present on the upper eyelids, nose, nasolabial folds, and the 
upper lip in the mother of the proband. B, Pedigree of the family: for individuals whose 
DNA samples have been analyzed, the allele sequences at codon 896 have been 
indicated as G (glycine) or A (alanine). The proband (arrow) encodes for a G on both 
alleles (G/G), whereas the affected family members are heterozygous for the mutation 
(black circles) encode an A on the mutant allele. 
 
 
Figure 2. Genetic analysis of the family with multiple familial trichoepithelioma. 
Shown are wild-type DNA (A) and mutant sequences (B) of exon 20 of CYLD from 
control and affected members, respectively. 
